posted on Mar 21 by MedPage Today OB/Gyn in the Uncategorized category
SAN FRANCISCO (MedPage Today) -- Intraperitoneal (IP) carboplatin might offer a better-tolerated alternative to intraperitoneal cisplatin for treatment of advanced ovarian cancer, results of a preliminary clinical study suggest.